A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose ...

New research on tirzepatide, the drug behind Zepbound and Mounjaro, suggests it could significantly lower the risk of major cardiovascular event.

Australia’s leading heart experts are recommending weight loss drugs be used to help reduce heart attacks and strokes, adding ...

Forty years after the first statin drug started lowering levels of artery-choking cholesterol, heart attacks and strokes remain the world’s biggest killers. This year will see test results on some ...

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.

Novartis, Amgen and Eli Lilly are betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology.

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Millions of Americans take prescription medications every day, trusting the drugs they rely on are safe, effective and ...

Early treatment with the aldosterone antagonist eplerenone (Inspra, Pfizer) plus an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin-receptor blocker (ARB) slows the progression of ...